Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Sep 11, 2024 3:34am
286 Views
Post# 36217999

RE:Me not smart...

RE:Me not smart...
thadeush wrote: but this latest news about the herpes virus is incredible. It adds to what already appears to be a whole other treatment area for TLT - that of eradicating viruses in the body, SARSCOVID2 included, for which there is currently no cure or even effective treatment. I wouldn't be surprised if these blood treatments are eventually spun off from the cancer treatments as a powerful separate opportunity. 



Menosome (not to be confused with menoalittle)...& that is, the specialized mechanism of action(s) utilized in our modifiable ruthenium-based drug gives it the ability/potential to treat so many unmet conditions in both the oncology & infectious disease spaces.  When comparing our drug tech to the current SOC for the above spaces, the potential here seems unmatched imo.

Chemo & radiation may also be effective across multiple cancer types, however, their effectiveness/benefit is either limited &/or short-term.  They are also not very specific, often require frequent dosing, & their inherent toxicity/drug-resistance can both limit their longer-term use & negatively impact quality of life.  Immunotherapy has shown promise as being more specific, but IT also generally requires frequent/longer-term maintenance dosing, increasing one's risk of side effects, resistance & poor patient compliance....not to mention added cost/patient burden.

When considering the above & treatment cost, our ACT certainly has a big advantage as a two or one-and-done treatment.  Re: $ cost burden, increasingly more HMOs & governments are incorporating cost effectiveness analyses (CEA) into their formulary decision-making.  In other words, if your drug doesn't give enough bang for its buck, it can be dropped for a cheaper alternative.  In these inflationary times, there is certainly growing pressure globally to control healthcare costs, & such a CEA strategy at both the public & private sectors will only expand imo. 

If you look at the "overall" potential of our ACT from just about any angle, we pretty much stand alone imo.  However, to steal a Notapoop metaphor, we need to at least land on GO before we can realize anything.  We know this question will be answered shortly, but I'd much rather land on Community Chest ; )


<< Previous
Bullboard Posts
Next >>